annual EBIT:
-$212.60M+$385.90M(+64.48%)Summary
- As of today (June 1, 2025), SMMT annual earnings before interest & taxes is -$212.60 million, with the most recent change of +$385.90 million (+64.48%) on December 31, 2024.
- During the last 3 years, SMMT annual EBIT has fallen by -$124.24 million (-140.61%).
- SMMT annual EBIT is now -2291.10% below its all-time high of $9.70 million, reached on January 31, 2019.
Performance
SMMT EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$62.91M-$1.75M(-2.85%)Summary
- As of today (June 1, 2025), SMMT quarterly earnings before interest & taxes is -$62.91 million, with the most recent change of -$1.75 million (-2.85%) on March 31, 2025.
- Over the past year, SMMT quarterly EBIT has dropped by -$22.56 million (-55.91%).
- SMMT quarterly EBIT is now -275.62% below its all-time high of $35.82 million, reached on July 31, 2018.
Performance
SMMT quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$235.16M-$22.56M(-10.61%)Summary
- As of today (June 1, 2025), SMMT TTM earnings before interest & taxes is -$235.16 million, with the most recent change of -$22.56 million (-10.61%) on March 31, 2025.
- Over the past year, SMMT TTM EBIT has dropped by -$130.36 million (-124.38%).
- SMMT TTM EBIT is now -1905.45% below its all-time high of $13.03 million, reached on April 1, 2019.
Performance
SMMT TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
SMMT EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +64.5% | -55.9% | -124.4% |
| 3 y3 years | -140.6% | -196.1% | -155.2% |
| 5 y5 years | -638.2% | -573.6% | -778.9% |
SMMT EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -173.1% | +64.5% | -415.6% | +88.2% | -216.2% | +60.7% |
| 5 y | 5-year | -638.2% | +64.5% | -573.6% | +88.2% | -778.9% | +60.7% |
| alltime | all time | -2291.1% | +64.5% | -275.6% | +88.2% | -1905.5% | +60.7% |
SMMT EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$62.91M(+2.9%) | -$235.16M(+10.6%) |
| Dec 2024 | -$212.60M(-64.5%) | -$61.17M(+13.7%) | -$212.60M(+14.8%) |
| Sep 2024 | - | -$53.80M(-6.1%) | -$185.14M(+23.5%) |
| Jun 2024 | - | -$57.28M(+42.0%) | -$149.89M(+43.0%) |
| Mar 2024 | - | -$40.35M(+19.7%) | -$104.81M(-82.5%) |
| Dec 2023 | -$598.50M(+668.9%) | -$33.70M(+81.7%) | -$598.50M(+3.0%) |
| Sep 2023 | - | -$18.55M(+52.0%) | -$581.12M(-0.4%) |
| Jun 2023 | - | -$12.20M(-97.7%) | -$583.27M(-0.7%) |
| Mar 2023 | - | -$534.05M(+3171.4%) | -$587.18M(+689.4%) |
| Dec 2022 | -$77.84M(-11.9%) | -$16.32M(-21.1%) | -$74.38M(-12.7%) |
| Sep 2022 | - | -$20.69M(+28.4%) | -$85.16M(+1.3%) |
| Jun 2022 | - | -$16.12M(-24.1%) | -$84.06M(-8.8%) |
| Mar 2022 | - | -$21.25M(-21.6%) | -$92.14M(+4.9%) |
| Dec 2021 | -$88.36M(+67.8%) | -$27.10M(+38.3%) | -$87.82M(+21.0%) |
| Sep 2021 | - | -$19.60M(-19.0%) | -$72.60M(+5.1%) |
| Jun 2021 | - | -$24.20M(+43.0%) | -$69.08M(+14.7%) |
| Mar 2021 | - | -$16.92M(+42.5%) | -$60.24M(+14.4%) |
| Dec 2020 | -$52.66M(+82.8%) | - | - |
| Dec 2020 | - | -$11.88M(-26.1%) | -$52.66M(+29.1%) |
| Sep 2020 | - | -$16.08M(+4.7%) | -$40.78M(+17.8%) |
| Jun 2020 | - | -$15.36M(+64.4%) | -$34.62M(+29.4%) |
| Mar 2020 | - | -$9.34M(-5.9%) | -$26.76M(-5.6%) |
| Dec 2019 | -$28.80M(-396.8%) | - | - |
| Oct 2019 | - | -$9.93M(+32.5%) | -$28.33M(-6.5%) |
| Jul 2019 | - | -$7.49M(+20.5%) | -$30.29M(-332.5%) |
| Apr 2019 | - | -$6.21M(+32.1%) | $13.03M(+28.1%) |
| Jan 2019 | $9.70M(-129.6%) | - | - |
| Jan 2019 | - | -$4.70M(-60.4%) | $10.17M(-674.4%) |
| Oct 2018 | - | -$11.88M(-133.2%) | -$1.77M(-124.2%) |
| Jul 2018 | - | $35.82M(-494.9%) | $7.32M(-121.4%) |
| Apr 2018 | - | -$9.07M | -$34.22M |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jan 2018 | -$32.76M(+5.5%) | - | - |
| Jan 2018 | - | -$16.64M(+496.2%) | -$32.57M(+35.3%) |
| Oct 2017 | - | -$2.79M(-51.1%) | -$24.08M(-13.2%) |
| Jul 2017 | - | -$5.71M(-23.1%) | -$27.74M(-12.4%) |
| Apr 2017 | - | -$7.42M(-9.0%) | -$31.67M(-4.8%) |
| Jan 2017 | -$31.06M(+7.2%) | - | - |
| Jan 2017 | - | -$8.15M(+26.4%) | -$33.27M(+3.2%) |
| Oct 2016 | - | -$6.45M(-33.1%) | -$32.25M(-5.8%) |
| Jul 2016 | - | -$9.64M(+6.8%) | -$34.24M(+6.7%) |
| Apr 2016 | - | -$9.03M(+26.5%) | -$32.09M(+10.9%) |
| Jan 2016 | -$28.98M(+57.9%) | - | - |
| Jan 2016 | - | -$7.14M(-15.4%) | -$28.92M(+13.6%) |
| Oct 2015 | - | -$8.44M(+12.7%) | -$25.47M(+18.6%) |
| Jul 2015 | - | -$7.49M(+27.7%) | -$21.47M(+7.2%) |
| Apr 2015 | - | -$5.86M(+59.1%) | -$20.03M(+5.9%) |
| Jan 2015 | -$18.35M(+65.9%) | - | - |
| Jan 2015 | - | -$3.68M(-17.0%) | -$18.91M(-2.5%) |
| Oct 2014 | - | -$4.44M(-26.6%) | -$19.40M(+6.5%) |
| Jul 2014 | - | -$6.05M(+27.5%) | -$18.22M(+49.7%) |
| Apr 2014 | - | -$4.74M(+13.7%) | -$12.17M(+63.8%) |
| Jan 2014 | -$11.07M(+53.2%) | - | - |
| Jan 2014 | - | -$4.17M(+28.0%) | -$7.43M(+128.0%) |
| Oct 2013 | - | -$3.26M | -$3.26M |
| Jan 2013 | -$7.22M(+53.5%) | - | - |
| Jan 2012 | -$4.70M(-49.7%) | - | - |
| Jan 2011 | -$9.36M(+1.8%) | - | - |
| Jan 2010 | -$9.19M(-51.0%) | - | - |
| Jan 2009 | -$18.76M(-14.2%) | - | - |
| Jan 2008 | -$21.86M(+218.2%) | - | - |
| Jan 2007 | -$6.87M(+113.8%) | - | - |
| Jan 2006 | -$3.21M(+498.8%) | - | - |
| Jan 2005 | -$536.60K | - | - |
FAQ
- What is Summit Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Summit Therapeutics?
- What is Summit Therapeutics annual EBIT year-on-year change?
- What is Summit Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Summit Therapeutics?
- What is Summit Therapeutics quarterly EBIT year-on-year change?
- What is Summit Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Summit Therapeutics?
- What is Summit Therapeutics TTM EBIT year-on-year change?
What is Summit Therapeutics annual earnings before interest & taxes?
The current annual EBIT of SMMT is -$212.60M
What is the all time high annual EBIT for Summit Therapeutics?
Summit Therapeutics all-time high annual earnings before interest & taxes is $9.70M
What is Summit Therapeutics annual EBIT year-on-year change?
Over the past year, SMMT annual earnings before interest & taxes has changed by +$385.90M (+64.48%)
What is Summit Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of SMMT is -$62.91M
What is the all time high quarterly EBIT for Summit Therapeutics?
Summit Therapeutics all-time high quarterly earnings before interest & taxes is $35.82M
What is Summit Therapeutics quarterly EBIT year-on-year change?
Over the past year, SMMT quarterly earnings before interest & taxes has changed by -$22.56M (-55.91%)
What is Summit Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of SMMT is -$235.16M
What is the all time high TTM EBIT for Summit Therapeutics?
Summit Therapeutics all-time high TTM earnings before interest & taxes is $13.03M
What is Summit Therapeutics TTM EBIT year-on-year change?
Over the past year, SMMT TTM earnings before interest & taxes has changed by -$130.36M (-124.38%)